Rot in foundation exposed. IMO, KL backstopping chairman'sIMO, poor corporate governance has shaken market confidence in KL's future. KL earned 132 million, in 2017. 61 million of it was spent on Novo shares, 6.9M on Bonterra, 6.7M on Metanor, and 3.8M on DeGrey; all backstopping (my term) shares the chairman of the board had bought previously for his personal account. This behavior continues, with 15M spent just recently buying Novo shares at $5 CAD, an above market rate.